SCHEMBL148684

SCHEMBL148684

[CH2]O[C]=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL239673 0.67
Carbon Dioxide SCHEMBL27603640 0.60
SCHEMBL58696 0.59
SCHEMBL384339 0.59
SCHEMBL2093635 0.56
SCHEMBL7040130 0.56
SCHEMBL8814778 0.56
SCHEMBL3215285 0.56
SCHEMBL156869 0.56
SCHEMBL7440813 0.56

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 773 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114349648-A Preparation method of chiral amine compound 深圳先进技术研究院 2022-04-15 CN claimed
CN-112592436-A Preparation method of shrinkage-reducing macromonomer and shrinkage-reducing polycarboxylate superplasticizer 北京金隅水泥节能科技有限公司 2021-04-02 CN claimed
CN-108699694-B Electroless plating base agent comprising highly branched polymer and metal fine particles 日产化学株式会社 2021-03-12 CN claimed
US-20200369640-A1 PROCESS FOR PREPARING CYCLIC CARBONATES BASF SE (DE) 2020-11-26 US claimed
US-20200338098-A1 Conjoint Therapies with Inhibitors of Glucose Production VIKING THERAPEUTICS, INC. 2020-10-29 US claimed
CN-110591655-A Method for preparing phase change latent heat material by modifying polyethylene glycol compound 北京工业大学 2019-12-20 CN claimed
US-20180353523-A1 CONJOINT THERAPIES WITH INHIBITORS OF GLUCOSE PRODUCTION VIKING THERAPEUTICS 2018-12-13 US claimed
EP-3352762-A1 CONJOINT THERAPIES WITH INHIBITORS OF GLUCOSE PRODUCTION Viking Therapeutics (US) 2018-08-01 EP claimed
EP-3331851-A1 BETA-SUBSTITUTED BETA-AMINO ACIDS AND ANALOGS AS CHEMOTHERAPEUTIC AGENTS AND USES THEREOF Quadriga Biosciences, Inc. (US) 2018-06-13 EP claimed
US-9937139-B2 β-substituted γ-amino acids and analogs as chemotherapeutic agents QUADRIGA BIOSCIENCES, INC. (US) 2018-04-10 US claimed
WO-2000014095-A1 NOVEL HETEROAROMATIC INHIBITORS OF FRUCTOSE 1,6-BISPHOSPHATASE METABASIS THERAPEUTICS, INC. (US) 2000-03-16 WO claimed
US-5869665-A REACTING 2-HYDRAZINE PRECURSOR WITH HYDROGEN; CYCLIZATION WARNER-LAMBERT COMPANY (US) 1999-02-09 US claimed
WO-1999003843-A1 POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM RHONE-POULENC RORER S.A. (FR) 1999-01-28 WO claimed
US-5756502-A APPETITE SUPPRESSANTS AND ANTISECRETORY AGENTS WARNER-LAMBERT COMPANY (US) 1998-05-26 US claimed
EP-0498188-B1 Oximethers and fungicides containing them BASF AG (DE) 1996-03-27 EP claimed
EP-0477631-A1 Ortho substituted phenylacetic acid amides BASF Aktiengesellschaft (DE) 1992-04-01 EP claimed
EP-0111809-A1 Pyrazolo(4.3-b)(1.4)oxazines, processes for their preparation and their use as medicaments Troponwerke GmbH &amp; Co. KG (DE) 1984-06-27 EP claimed
EP-0085881-A2 Pyrazolooxazines, -thiazines and -quinolines, process for their preparation and their use as medicaments BAYER AG (DE) 1983-08-17 EP claimed
US-4324723-A Monoazo dyestuffs BAYER AKTIENGESELLSCHAFT (DE) 1982-04-13 US claimed
US-4154756-A HYPOLIPIDEMIC AND ANTIATHEROSCLEROTIC AGENTS AMERICAN CYANAMID COMPANY (US) 1979-05-15 US claimed